Keyphrases
B Cells
85%
Autoantibodies
45%
Anti-DNA Antibodies
33%
Complementarity-determining Region 3 (CDR3)
28%
Phosphatidylcholine
27%
Acute Myeloid Leukemia
23%
Therapy-related Myeloid Neoplasms
19%
Lymphoma
19%
Bone Marrow
17%
Heavy Chain
16%
Site-directed
15%
Myelodysplastic Syndrome
15%
Myeloid Neoplasms
15%
Chronic Myeloid Leukemia
15%
T Cells
15%
TP53 mutation
14%
Somatic mutation
14%
Point mutation
14%
Transgenic Mice
14%
Clinical Characteristics
13%
Lpr Mice
13%
Mantle Cell Lymphoma
13%
Hodgkin Lymphoma
13%
Single Institution
13%
Marginal Zone Lymphoma
13%
Decitabine
13%
Leukemia
13%
Murine Model
13%
Acute Promyelocytic Leukemia
13%
Gray Zone
13%
Chronic Lymphocytic Leukemia
13%
Novel Therapies
13%
Single-stranded DNA (ssDNA)
13%
V Genes
12%
Overall Survival
12%
Autoimmune
11%
Wastage
10%
Novel Mechanism
10%
FDG Uptake
9%
Cytomegalovirus Reactivation
9%
FDG-avid
9%
Spleen
9%
Genomic Instability
9%
Tumor Protein p53 (TP53)
9%
Chemotherapy
9%
Transgenic
8%
Fluorescence in Situ Hybridization
8%
Peripheral T-cell Lymphoma
8%
Latently Infected
8%
Receptor Editing
8%
Immunology and Microbiology
B Cell
100%
Natural Autoantibody
26%
Autoantibodies
23%
Transgenic Mouse
22%
Complementarity Determining Region
21%
T Cell
20%
Autoimmunity
19%
Heavy Chain
17%
Immunoglobulin M
14%
Lupus Erythematosus
14%
T-Helper Cell
13%
Cytomegalovirus
13%
Point Mutation
12%
Intravenous Immunoglobulin
11%
Somatic Mutation
10%
Transgenics
9%
Mouse Model
8%
Receptor Editing
8%
Murine
8%
Amino Acid
7%
Keyhole Limpet Hemocyanin
7%
Transgene
6%
Immunosuppression
6%
Lymphoproliferative Disorders
6%
Somatic Hypermutation
6%
Memory B Cell
6%
Murine Cytomegalovirus
6%
Secretion (Process)
6%
Amino Acid Substitution
6%
Immunoglobulin Heavy Chain
6%
Hepatitis C Virus
6%
Chronic Graft Versus Host Disease
6%
Immune Response
6%
Immunoglobulin Heavy Chain Gene
6%
Drug-Induced Lupus Erythematosus
6%
Nephritis
6%
B-Cell Receptor
6%
Immunoglobulin Deposition
6%
Precursor
6%
Cell Cycle
6%
Hematopoietic Cell
6%
Fluorescence in Situ Hybridization
6%
Dendritic Cell
6%
Binding Antibody
6%
Amino Acid Sequence
6%
Cell Expansion
6%
Gamma Delta T Cell
6%
Light Chain
5%
Systemic Lupus Erythematosus
5%
DNA Antibody
5%
Medicine and Dentistry
Neoplasm
41%
Acute Myeloid Leukemia
29%
Myelodysplastic Syndrome
16%
Morphology
13%
Decitabine
13%
Hodgkin's Lymphoma
13%
MALT Lymphoma
13%
Leukemia
13%
Lymphocytic Lymphoma
13%
B-Cell Chronic Lymphocytic Leukemia
13%
T-Cell Lymphoma
9%
Lymphadenopathy
9%
Chromosome Aberration
8%
Diseases
8%
Chronic Myelomonocytic Leukemia
8%
Imatinib
8%
Diffuse Large B-Cell Lymphoma
8%
Overall Survival
7%
Positron Emission Tomography-Computed Tomography
7%
B Cell
7%
Thrombocytopenia
7%
B Lymphocyte Receptor
6%
Programmed Death 1 Ligand 1
6%
Mantle Cell Lymphoma
6%
Angiosarcoma
6%
Subscapularis Muscle
6%
Urticaria Pigmentosa
6%
Fluorodeoxyglucose F 18
6%
Myeloid Sarcoma
6%
False Positive Result
6%
Azacitidine
6%
Schistocyte
6%
Hypochromic Anemia
6%
Echinocyte
6%
Cytomegalovirus
6%
Acute Erythroid Leukemia
6%
Lung Lavage
6%
Murine Cytomegalovirus
6%
Peritenon
6%
COVID-19
6%
Initiation Factor 4A
6%
RNA Helicase
6%
Radioactive Iodine
6%
Cutaneous T Cell Lymphoma
6%
Immunosuppressive Treatment
6%
Giant Cell Tumor
6%
DNA B
6%
Vaginal Wall
6%
Follicular Lymphoma
6%
Kidney Graft
6%
